A study of almost 2000 people published in February 2021 has shown that a new, once-a-week weight loss injection can help patients with obesity significantly reduce their body weight and improve their health alongside their weight loss diet.
The study, undertaken by University College London, found that 32% of people who took semaglutide were able to reduce their overall body weight by 20%, in just 15 months when accompanied by a healthy weight loss diet.
What is Semaglutide?
Semaglutide is an injectable weight loss medication that works on the appetite receptors in the brain to reduce feelings of hunger and cravings.
The injection imitates GLP1 – a naturally occurring hormone in your body – which is released after you eat and indicates to your brain that you are full. These medications also work to slow the emptying of your stomach, which leads to feelings of fullness for longer after you have eaten.
Prior to this trial, semaglutide was used for the purposes of treating those with type 2 diabetes to improve glycemic control in adults. Advantages of semaglutide include its robust and sustained effects on glucose levels and weight loss.
Benefits of Semaglutide
- Decrease in Body Fat
- Decrease in weight
- May Suppress Appetite
- Improved blood sugar regulation
- More control over insulin
- Reduce food cravings
Learn more about Semaglutide here: FAQs and Precautions
